| |
| |
|
| Insider
Information: |
Gold Mitchell |
| Relationship: |
Executive Chairman and... |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
457,263 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
457,263 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2013-01-03 |
457,263 |
2003-09-03 |
0 |
Premium* |
|
|
Alpine Immune Sciences Inc |
ALPN |
Executive Chairman and... |
2024-05-20 |
0 |
2024-05-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2023-12-19 |
4 |
AS |
$20.01 |
$48,064 |
D/D |
(2,402) |
0 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-07-17 |
4 |
D |
$22.99 |
$48,785 |
D/D |
(2,122) |
484,414 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-21 |
4 |
D |
$39.13 |
$50,126 |
D/D |
(1,281) |
244,785 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-21 |
4 |
D |
$40.89 |
$52,380 |
D/D |
(1,281) |
282,412 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• • – |
2007-01-12 |
4 |
D |
$4.23 |
$55,180 |
D/D |
(13,045) |
206,638 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2009-10-17 |
4 |
D |
$29.51 |
$62,620 |
D/D |
(2,122) |
480,157 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-07-17 |
4 |
D |
$31.29 |
$66,397 |
D/D |
(2,122) |
218,251 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-09-16 |
4 |
AS |
$10.00 |
$67,696 |
D/D |
(6,768) |
154,649 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• • – |
2011-01-20 |
4 |
D |
$13.37 |
$68,347 |
D/D |
(5,112) |
671,057 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-01-17 |
4 |
D |
$37.16 |
$78,854 |
D/D |
(2,122) |
239,680 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2020-06-30 |
4 |
D |
$9.71 |
$79,884 |
D/D |
(8,227) |
60,634 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-10-17 |
4 |
D |
$37.83 |
$80,275 |
D/D |
(2,122) |
211,289 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-07-17 |
4 |
D |
$38.80 |
$82,334 |
D/D |
(2,122) |
246,066 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & CEO |
• – – |
2010-04-17 |
4 |
D |
$38.90 |
$82,546 |
D/D |
(2,122) |
509,876 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-03 |
4 |
OE |
$4.41 |
$86,975 |
D/D |
19,000 |
296,301 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-17 |
4 |
D |
$42.40 |
$89,973 |
D/D |
(2,122) |
283,693 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-03-25 |
4 |
OE |
$4.90 |
$93,100 |
D/D |
19,000 |
308,801 |
0 |
- |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-04-25 |
4 |
OE |
$4.90 |
$93,100 |
D/D |
19,000 |
301,412 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-06-25 |
4 |
AS |
$10.01 |
$94,865 |
D/D |
(9,473) |
168,380 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • – |
2024-05-08 |
4 |
OE |
$7.55 |
$100,000 |
D/D |
13,245 |
109,245 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-13 |
4 |
AS |
$10.07 |
$100,714 |
D/D |
(10,000) |
260,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-04-14 |
4 |
AS |
$10.52 |
$105,200 |
D/D |
(10,000) |
250,039 |
0 |
% |
|
| DNDN |
Dendreon Corp |
President & Chief Executive Of |
• – – |
2011-01-15 |
4 |
D |
$37.16 |
$114,936 |
D/D |
(3,093) |
241,802 |
0 |
- |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-13 |
4 |
AS |
$11.52 |
$115,169 |
D/D |
(10,000) |
230,039 |
0 |
% |
|
| ALPN |
Alpine Immune Sciences In... |
Executive Chairman and CEO |
• • • |
2021-05-12 |
4 |
AS |
$11.68 |
$116,842 |
D/D |
(10,000) |
240,039 |
0 |
% |
|
140 Records found
|
|
Page 4 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
